Congress Holds Off on Enabling FDA Regulation of Clinical Laboratory-Developed Tests
Supporters of the VALID Act say lobbying blitz by academic medical centers prevented its passage In 2022, a bill before Congress titled the Verifying Accurate Leading-Edge IVCT Development Act (VALID Act) sought to change the current regulatory scheme for clinical laboratory-developed tests (LDTs) and in vitro clinical tests (IVCTs). But even though the College of […]
The post <strong>Congress Holds Off on Enabling FDA Regulation of Clinical Laboratory-Developed Tests</strong> appeared first on Dark Daily.
Source: Dark Daily - Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Compliance, Legal, and Malpractice Laboratory Pathology Laboratory Resources Laboratory Sales and Marketing Laboratory Testing AACC AAMC AdvaMed American Association for Clinical Chemistry American Cancer Society Cancer Action Network Source Type: news
More News: AAMC | Academia | Cancer | Cancer & Oncology | Chemistry | Laboratory Medicine | Legislation | Malpractice | Marketing | Pathology | Politics